Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer

Frontiers in Oncology

Oncology

Wenchu Lin¹  Xing Bian²  Xiaolin Wang²  Guozhen Cao²  Liying Ma²  Jinhua Han³  Jun Huang³  Qiuyan Zhang⁴  Ao Xu⁵ 

[1] High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China;Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China;High Magnetic Field Laboratory of Anhui Province, Hefei, China;High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, China;University of Science and Technology of China, Hefei, China;Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China;High Magnetic Field Laboratory of Anhui Province, Hefei, China;MOE Key Laboratory for Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China;The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Signaling Network, School of Life Sciences, University of Science and Technology of China, Hefei, China;The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China;Department of Pathology, Anhui Provincial Hospital, Hefei, China;

关键词: small cell lung cancer;    MYC paralog;    PARP1;    BET;    DNA damage response;   

DOI  :  10.3389/fonc.2023.1192526

 received in 2023-03-23, accepted in 2023-03-27,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Bian, Wang, Zhang, Ma, Cao, Xu, Han, Huang and Lin